Activation of contact phase of blood coagulation can be induced by the sclerosing agent polidocanol: possible additional mechanism of adverse reaction during sclerotherapy.
D001777:Blood Coagulation / Q000187:drug effects*; D005174:Factor XII / Q000378:metabolism; D006487:Hemostasis / Q000187:drug effects; D006801:Humans; D066298:In Vitro Techniques; D000077423:Polidocanol; D011092:Polyethylene Glycols / Q000009:adverse effects / Q000494:pharmacology*; D011288:Prekallikrein / Q000378:metabolism
D000077423:Polidocanol; D011092:Polyethylene Glycols; D005174:Factor XII; D011288:Prekallikrein